Authors:
ISHII T
SATO M
SUDO K
SUZUKI M
NAKAI H
HISHIDA T
NIWA T
UMEZU K
YUASA S
Citation: T. Ishii et al., HEPATOCYTE GROWTH-FACTOR STIMULATES LIVER-REGENERATION AND ELEVATES BLOOD PROTEIN LEVEL IN NORMAL AND PARTIALLY HEPATECTOMIZED RATS, Journal of Biochemistry, 117(5), 1995, pp. 1105-1112
Authors:
MATSUMOTO K
NAGASHIMA K
KAMIGAUCHI T
KAWAMURA Y
YASUDA Y
ISHII K
UOTANI N
SATO T
NAKAI H
TERUI Y
KIKUCHI J
IKENISI Y
YOSHIDA T
KATO T
ITAZAKI H
Citation: K. Matsumoto et al., SALFREDINS, NEW ALDOSE REDUCTASE INHIBITORS PRODUCED BY CRUCIBULUM SPRF-3817 .1. FERMENTATION, ISOLATION AND STRUCTURES OF SALFREDINS, Journal of antibiotics, 48(6), 1995, pp. 439-446
Authors:
TAKANO K
TANAKA T
FUJITA T
NAKAI H
YONEMASU Y
Citation: K. Takano et al., ZONISAMIDE - ELECTROPHYSIOLOGICAL AND METABOLIC CHANGES IN KAINIC ACID-INDUCED LIMBIC SEIZURES IN RATS, Epilepsia, 36(7), 1995, pp. 644-648
Authors:
YASUDA S
HORAI Y
TOMONO Y
NAKAI H
YAMATO C
MANABE K
KOBAYASHI K
CHIBA K
ISHIZAKI T
Citation: S. Yasuda et al., COMPARISON OF THE KINETIC DISPOSITION AND METABOLISM OF E3810, A NEW PROTON PUMP INHIBITOR, AND OMEPRAZOLE IN RELATION TO S-MEPHENYTOIN 4'-HYDROXYLATION STATUS, Clinical pharmacology and therapeutics, 58(2), 1995, pp. 143-154
Citation: K. Ishii et al., SIMULTANEOUS ASSAY OF 4 STEREOISOMERS OF DILTIAZEM HYDROCHLORIDE - APPLICATION TO IN-VITRO CHIRAL INVERSION STUDIES, Chromatographia, 41(7-8), 1995, pp. 450-454
Citation: H. Nishi et al., ENANTIOMERIC SEPARATION OF TRIMETOQUINOL, DENOPAMINE AND TIMEPIDIUM BY CAPILLARY ELECTROPHORESIS AND HPLC AND THE APPLICATION OF CAPILLARY ELECTROPHORESIS TO THE OPTICAL PURITY TESTING OF THE DRUGS, Chromatographia, 40(11-12), 1995, pp. 638-644
Authors:
HASHIMOTO A
YAMASAKI K
KOKUSENYA Y
MIYAMOTO T
NAKAI H
SATO T
Citation: A. Hashimoto et al., STUDY ON SIGNAL CONSTITUENTS FOR THE EVALUATION OF ANIMAL CRUDE DRUGS.2. ORGANIC-ACIDS, Chemical and Pharmaceutical Bulletin, 43(12), 1995, pp. 2195-2199
Authors:
SHIMA M
NAKAI H
SCANDELLA D
TANAKA I
SAWAMOTO Y
KAMISUE S
MORICHIKA S
MURAKAMI T
YOSHIOKA A
Citation: M. Shima et al., COMMON INHIBITORY EFFECTS OF HUMAN ANTI-C2 DOMAIN INHIBITOR ALLOANTIBODIES ON FACTOR-VIII BINDING TO VON-WILLEBRAND-FACTOR, British Journal of Haematology, 91(3), 1995, pp. 714-721
Authors:
NAKAI H
MISAWA S
HORIIKE S
MAEKAWA T
KASHIMA K
ISHIZAKI K
Citation: H. Nakai et al., HEMIZYGOTIC EXPRESSION OF THE WILD-TYPE P53 ALLELE MAY CONFER A SELECTIVE GROWTH ADVANTAGE BEFORE COMPLETE INACTIVATION OF THE P53 GENE IN THE PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA, British Journal of Haematology, 90(1), 1995, pp. 147-155
Authors:
SCANDELLA D
GILBERT GE
SHIMA M
NAKAI H
EAGLESON C
FELCH M
PRESCOTT R
RAJALAKSHMI KJ
HOYER LW
SAENKO E
Citation: D. Scandella et al., SOME FACTOR-VIII INHIBITOR ANTIBODIES RECOGNIZE A COMMON EPITOPE CORRESPONDING TO C2 DOMAIN AMINO-ACIDS-2248 THROUGH AMINO-ACIDS-2312, WHICH OVERLAP A PHOSPHOLIPID-BINDING SITE, Blood, 86(5), 1995, pp. 1811-1819
Authors:
SHIMA M
NAKAI H
SCANDELLA D
TANAKA I
SAWAMOTO Y
KAMISUE S
MORICHIKA S
MURAKAMI T
YOSHIOKA A
Citation: M. Shima et al., COMMON INHIBITORY EFFECTS OF HUMAN ANTI-C2 DOMAIN INHIBITOR ALLOANTIBODIES ON FACTOR-VIII BINDING TO VON-WILLEBRAND-FACTOR, Blood, 86(10), 1995, pp. 748-748
Authors:
KANEKO H
MISAWA S
HORIIKE S
NAKAI H
KASHIMA K
Citation: H. Kaneko et al., TP53 MUTATIONS EMERGE AT EARLY PHASE OF MYELODYSPLASTIC SYNDROME AND ARE ASSOCIATED WITH COMPLEX CHROMOSOMAL-ABNORMALITIES, Blood, 85(8), 1995, pp. 2189-2193
Authors:
ODAGAKI Y
NAKAI H
SENOKUCHI K
KAWAMURA M
HAMANAKA N
NAKAMURA M
TOMOO K
ISHIDA T
Citation: Y. Odagaki et al., UNIQUE BINDING OF A NOVEL SYNTHETIC INHIBITOR, BONYL]PHENYL]-2-METHYL-2-PROPENOY1]-N-ALLYLGLYCINE METHANESULFONATE, TO BOVINE TRYPSIN, REVEALED BY THE CRYSTAL-STRUCTURE OF THE COMPLEX, Biochemistry, 34(39), 1995, pp. 12849-12853
Authors:
NAKAI H
OZAKI S
KANO S
KOMATSUBARA Y
KONDO S
SHIMIZU M
TAKASUGI K
HANYU T
MATSUNO H
MATSUBARA T
YAMANA S
GOTO N
Citation: H. Nakai et al., ASSOCIATED PROTECTION AGAINST SECONDARY AMYLOIDOSIS IN JAPANESE PATIENTS WITH RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 38(9), 1995, pp. 259-259
Citation: H. Nishi et al., ENANTIOMERIC SEPARATION OF DRUGS BY MUCOPOLYSACCHARIDE-MEDIATED ELECTROKINETIC CHROMATOGRAPHY, Analytical chemistry, 67(14), 1995, pp. 2334-2341
Citation: H. Nishi et al., CHIRAL SEPARATION OF DRUGS BY CAPILLARY ELECTROPHORESIS USING BETA-CYCLODEXTRIN POLYMER, Journal of chromatography, 678(2), 1994, pp. 333-342
Citation: H. Nakai et Y. Kamide, A MODEL OF THE LARGE-SCALE DISTRIBUTION OF THE NEUTRAL SHEET CURRENT AND ITS SUBSTORM-ASSOCIATED CHANGES, J GEO R-S P, 99(A2), 1994, pp. 2365-2373
Authors:
NAKAI H
SHIMAMURA Y
KANAZAWA T
YASUDA S
KAYANO M
Citation: H. Nakai et al., DETERMINATION OF A NEW H-K+ ATPASE INHIBITOR (E3810) AND ITS 4 METABOLITES IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY(), Journal of chromatography B. Biomedical applications, 660(1), 1994, pp. 211-220
Authors:
YASUDA S
OHNISHI A
OGAWA T
TOMONO Y
HASEGAWA J
NAKAI H
SHIMAMURA Y
MORISHITA N
Citation: S. Yasuda et al., PHARMACOKINETIC PROPERTIES OF E3810, A NEW PROTON PUMP INHIBITOR, IN HEALTHY MALE-VOLUNTEERS, International journal of clinical pharmacology and therapeutics, 32(9), 1994, pp. 466-473
Authors:
KOBAYASHI S
NAKAI H
KUNORI Y
NAKAYAMA T
MIYAWAKI Y
TERADA Y
ONODA H
AJIKA N
HATANAKA M
MIYOSHI H
YOSHIHARA T
Citation: S. Kobayashi et al., MEMORY ARRAY ARCHITECTURE AND DECODING SCHEME FOR 3-V ONLY SECTOR ERASABLE DINOR FLASH MEMORY, IEICE transactions on electronics, E77C(5), 1994, pp. 784-790
Citation: H. Nakai et R. Kruklitis, HOST PROTEINS REQUIRED TO CATALYZE BACTERIOPHAGE MU DNA-SYNTHESIS IN-VITRO, The FASEB journal, 8(7), 1994, pp. 10001332-10001332